Table 2 Relationship between the SUVmax and clinicopathological/IHC findings

Age

0.778

0.747

 <70 years

30

6.4 ± 5.1

11

8.4 ± 4.5

 ≥70 years

22

6.9 ± 5.3

21

8.9 ± 3.4

Sex

0.230

-

 Male

24

7.6 ± 5.5

32

8.8 ± 3.7

 Female

28

5.8 ± 4.8

0

Tumor differentiation

0.008

0.565

 Well

30

4.1 ± 3.3

2

12.0 ± 2.1

 Moderate

16

8.5 ± 5.4

21

8.3 ± 3.9

 Poor

6

14.1 ± 2.7

9

9.1 ± 3.6

Pleural invasion

0.001

0.077

 No

38

5.0 ± 4.0

26

8.2 ± 3.7

 Yes

14

11.1 ± 5.4

6

11.2 ± 3.2

Vascular invasion

0.001

0.602

 No

33

4.7 ± 4.0

18

9.1 ± 3.8

 Yes

19

9.9 ± 5.5

14

8.4 ± 3.7

Nodal status

0.007

0.075

 Negative

44

5.6 ± 4.6

26

8.1 ± 3.5

 Positive

8

12.0 ± 4.9

6

11.6 ± 3.7

Cox-2 expression

<0.001

0.048

 Negative

18

2.8 ± 2.4

19

7.7 ± 3.6

 Positive

34

8.7 ± 5.1

13

10.3 ± 3.5

Ki-67 expression

0.001

0.016

 Negative

26

4.3 ± 3.3

15

7.0 ± 4.0

 Positive

26

9.0 ± 5.7

17

10.3 ± 2.9

VEGF expression

0.004

0.719

 Negative

17

3.9 ± 4.1

16

9.0 ± 4.3

 Positive

35

8.0 ± 5.1

16

8.5 ± 3.3